Pi-Hui Liang

Title: Pi-Hui Liang: Innovator in Targeted Therapy and Vaccine Development

Introduction

Pi-Hui Liang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the fields of targeted therapy and vaccine development. With a total of 2 patents, his work focuses on innovative solutions for treating diseases and enhancing immune responses.

Latest Patents

One of his latest patents is titled "Conjugate for targeting therapy." This invention provides a novel conjugate or a pharmaceutically acceptable salt thereof, which includes an active pharmaceutical moiety or a prodrug, a targeting module, and a linker. This conjugate is designed to treat diseases, recurrence, or progression in subjects, thereby increasing the likelihood of survival for those diagnosed with a disease.

Another significant patent is "Saponin conjugate and vaccine or pharmaceutical composition comprising the same." This invention involves novel chemical compounds where a lipophilic moiety is covalently attached to a triterpene saponin via a carboxyl group. The attachment enhances the adjuvant effects on both humoral and cell-mediated immunity, making the saponin analog easier to purify, less toxic, and chemically more stable.

Career Highlights

Throughout his career, Pi-Hui Liang has worked with esteemed institutions, including National Taiwan University. His research has focused on developing innovative therapeutic solutions that address critical health challenges.

Collaborations

Pi-Hui Liang has collaborated with notable colleagues, including Yen-Hsun Lai and Chun-Kai Chang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pi-Hui Liang's contributions to targeted therapy and vaccine development highlight his role as an influential inventor in the medical field. His innovative patents reflect a commitment to improving health outcomes through scientific advancement.